These novel treatments, Tirzepatide , represent a remarkable advancement in treating metabolic dysfunction and potentially other disorders. They are categorized as GLP-1 hormone agonists , meaning they function to replicate the endogenous GLP-1 substance , enhancing glucose release and lowering appetite . Although Semaglutide every operates larg… Read More